Outlook Therapeutics News

Outlook Therapeutics | 8-K: Current report

10:41

Outlook Therapeutics | 10-Q: Quarterly report

May 16 05:22

Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

May 16 05:21

Outlook Therapeutics | 8-K: Current report

May 14 04:11

Outlook Therapeutics | EFFECT: Others

May 7 18:09

Outlook Therapeutics | 424B3: Prospectus

May 7 04:15

Outlook Therapeutics | 8-K: Current report

May 1 18:09

Outlook Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 27 04:23

Outlook Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Syntone Ventures LLC(11.4%),Syntone LLC(11.4%), etc.

Apr 18 09:40

Outlook Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Syntone Ventures LLC

Apr 18 08:25

Outlook Therapeutics | D: Filing D

Apr 17 05:26

Outlook Therapeutics | 8-K: Current report

Apr 16 04:55

Outlook Therapeutics | 424B5: Prospectus

Apr 13 04:29

Outlook Therapeutics | 8-K: Current report

Apr 13 04:08

Outlook Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%), etc.

Apr 9 04:15

Outlook Therapeutics | EFFECT: Others

Apr 8 18:07

Outlook Therapeutics | CORRESP: CORRESP

Apr 4 10:23

Outlook Therapeutics | UPLOAD: Others

Apr 4 10:17

Outlook Therapeutics | 8-K: Current report

Apr 3 04:23

Outlook Therapeutics | EFFECT: Others

Apr 2 18:09